Research article · 17 Oct 2023
Short communicationPublished 11 May 2021
From Angiotensin II to Angiotensin Receptor Blockers (ARBs): Insights and Perspectives of ARBs in Covid-19 Therapy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Pioneer research on the renin–angiotensin system (RAS) has resulted in the discovery of the first orally active non-peptide angiotensin II receptor antagonist losartan (DUP753). This discovery was followed by related non-peptide angiotensin receptor antagonists (ARBs) in the treatment of hypertension representing a breakthrough new generation of antihypertensives. Our group has been involved for years in the investigation of the mechanism through which angiotensin II exerts its hypertensive action. This research has led to new insights revealing the bioactive conformation of the hormone and the unique way angiotensin II is approaching its receptors. In particular, these studies revealed a ring cluster conformation and a charge relay system between the aromatic amino acids Tyr, His, and Phe of the peptide molecule analogous to the charge relay system observed in serine proteases. Angiotensin II receptor blockers (ARBS) and angiotensin I converting enzyme inhibitors (ACEI) were recently reported to protect hypertensive patients infected with SARS-CoV-2. The renin–angiotensin system (RAS) inhibitors reduce excess angiotensin II and increase antagonist heptapeptides alamandine and aspamandine which counterbalance angiotensin II and maintain homeostasis and vasodilation. A series of ARBs were designed and synthesized in our laboratories, currently investigated as potential SARS-CoV-2 inhibitors.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Pharmaceutical Microbiology.
Conference abstract · 27 Aug 2022
Fear among Syrians: a Proposed Cutoff Score for the Arabic Fear of the COVID 19 Scale
Conference abstract · 27 Aug 2022
ENTOMOTOXICOLOGY: AN EMERGING TOOL IN THE CRIMINAL INVESTIGATION
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmaceutical Microbiology
- SubjectPharmaceutical Sciences
- SubjectMicrobiology
- BylineArticles whose byline prints “John Matsoukas”
